Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypass;Avaliação da aprotinina na redução da resposta inflamatória sistêmica em crianças operadas com circulação extracorpórea

Brazilian Journal of Cardiovascular Surgery

Volumn 25, Issue 1, 2010, Pages 85-98

  Ferreira, Cesar Augusto ^a   de Andrade Vicente, Walter Villela ^a   Evora, Paulo Roberto Barbosa ^a   Rodrigues, Alfredo José ^a   Klamt, Jyrson Guilherme ^a   de Carvalho Panzeli Carlotti, Ana Paula ^a   Carmona, Fábio ^a   Manso, Paulo Henrique ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aprotinin; Capillary leak syndrome; Cardiovascular surgical procedures; Extracorporeal membrane oxygenation; Systemic inflammatory response syndrome

Indexed keywords

ANTIINFLAMMATORY AGENT; APROTININ; AUTACOID; INTERLEUKIN DERIVATIVE; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR;

ADVERSE EFFECTS; BLOOD; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; HEART DEFECTS, CONGENITAL; HUMAN; INFANT; MALE; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANTI-INFLAMMATORY AGENTS; APROTININ; CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFLAMMATION MEDIATORS; INTERLEUKINS; MALE; POSTOPERATIVE COMPLICATIONS; SERINE PROTEINASE INHIBITORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954233723     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/s0102-76382010000100018     Document Type: Article

References (36)

1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-6.
2. Seghaye MC. The clinical implications of the systemic inflammatory reaction related to cardiac operations in children. Cardiol Young. 2003;13(3):228-39.
3. Laffey JG, Boylan JF, Cheng DC. The systemic inflamatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 2002;97(1):215-52.
4. Wegner J. Biochemistry of serine protease inhibitors and their mechanisms of action: a review. J Extra Corpor Technol. 2003;35(4):326-38.
5. Oliver WC Jr, Fass DN, Nuttall GA, Dearani JA, Schrader LM, Schroeder DR, et al. Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2004;127(6):1670-7.
6. Mossinger H, Dietrich W, Braun SL, Jochum M, Meisner H, Richter JA. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg. 2003;75(2):430-7.
7. Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RD, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation. 2002;106(12 Suppl 1):I82-9.
8. Wippermann CF, Schmid FX, Eberle B, Huth RG, Kampmann C, Schranz D, et al. Reduced inotropic support after aprotinin therapy during pediatric cardiac operations. Ann Thorac Surg. 1999;67(1):173-6.
9. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22):2319-31.
10. Twite MD, Hammer GB. The use of aprotinin in pediatric cardiac surgery: should we bid 'good riddance' or are we throwing out the baby with the bath water? Paediatr Anesth. 2008;18(9):809-11.
11. Backer CL, Kelle AM, Stewart RD, Suresh SC, Ali FN, Cohn RA, et al. Aprotinin is safe in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2007;134(6):1421-6.
12. Guzzetta NA, Evans FM, Rosenberg ES, Fazlollah TM, Baker MJ, Wilson EC, et al. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis. Anesth Analg. 2009;108(2):448-55.
13. Manrique A, Jooste EH, Kuch BA, Lichtenstein SE, Morell V, Munoz R, et al. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass. Anesth Analg. 2009;109(1):45-52.
14. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2-8.
15. Mattos SS, Neves JR, Costa MC, Hatem TP, Luna CF. An index for evaluating results in paediatric cardiac intensive care. Cardiol Young. 2006;16(4):369-77.
16. Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials os aprotinin. Anesth Analg. 2006;102(3):731-7.
17. Alcaraz AJ, Manzano L, Sancho L, Vigil MD, Esquivel F, Maroto E, et al. Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8. J Clin Immunol. 2005;25(3):238-45.
18. Seghaye MC, Duchateau J, Grabitz RG, Jablonka K, Wenzl T, Marcus C, et al. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg. 1996;61(4):1205-11.
19. Dubois J, Jamaer L, Mees U, Pauwels J, Briers F, Lehaen J, et al. Ex vivo evaluation of a new neonatal/infant oxygenator: comparison of the Terumo CAPIOX Baby RX with Dideco Lilliput 1 and Polystan Safe Micro in the piglet model. Perfusion. 2004:19(5):315-21.
20. Jensen E, Andréasson S, Bengtsson A, Berggren H, Ekroth R, Lindholm L, et al. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery. Ann Thorac Surg. 2003;75(3):919-25.
21. Chew MS, Brandslund I, Brix-Christensen V, Ravn HB, Hjortdal VE, Pedersen J, et al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology. 2001;94(5):745-53.
22. Mou SS, Haudek SB, Lequier L, Peña O, Leonard S, Nikaidoh H, et al. Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med. 2002; 30(4):827-32.
23. Hövels-Gurich HH, Schumacher K, Vazquez-Jimenez JF, Qing M, Huffmeier U, Buding B, et al. Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg. 2002;73(2):601-8.
24. Hövels-Gurich HH, Vazquez-Jimenez JF, Silvestri A, Schumacher K, Minkenberg R, Duchateau J, et al. Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg. 2002;124(4):811-20.
25. Brancaccio G, Villa E, Girolami E, Michielon G, Feltri C, Mazzera E, et al. Inflammatory cytokines in pediatric cardiac surgery and variable effect of the hemofiltration process. Perfusion. 2005;20(5):263-8.
26. Schmartz D, Tabardel Y, Preiser JC, Barvais L, d;HollanderA, Duchateau J, et al. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients? J Thorac Cardiovasc Surg. 2003;125(1):184-90.
27. Carmona F. Avaliação dos fatores de risco para disfunção miocárdica e mortalidade intra-hospitalar em neonatos e lactentes submetidos a cirurgia cardiaca com circulação extracorpórea [Dissertação de Mestrado]. Ribeirão Preto: Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo;2006. 153p.
28. Greilich PE, Brouse CF, Whitten CW, Chi L, Dimaio JM, Jessen ME. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin. J Thorac Cardiovasc Surg. 2003;126(5):1498-503.
29. Caputo M, Bays S, Rogers CA, Pawade A, Parry AJ, Suleiman S, et al. Randomized comparison between normothermic and hypothermic cardiopulmonary bypass in pediatric open-heart surgery. Ann Thorac Surg. 2005;80(3):982-8.
30. Sugita T, Watarida S, Katsuyama K, Nakajima Y, Yamamoto R, Mori A. Interleukin-10 concentration in children undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112(4):1127-8.
31. Tárnok A, Hambsch J, Schneider P. Cardiopulmonary bypass-induced increase of serum interleukin-10 levels in children. J Thorac Cardiovasc Surg. 1998;115(2):475-7.
32. Brown JR, Toler AW, Kramer RS, Landis RC. Anti-inflammatory effect of aprotinin: a meta-analysis. J Extra Corpor Technol. 2009;41(2):79-86.
33. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, KurokawaA. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med. 1999;27(7):1262-4.
34. Williams GD, Ramamoorthy C, Pentcheva K, Boltz MG, Kamra K, Reddy VM. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery. Pediatr Anesth. 2008;18(9):812-9.
35. Carrel TP, Schwanda M, Vogt PR, Turina MI. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only. Ann Thorac Surg. 1998;66(1):153-8.
36. Jaquiss RD, Huddleston CB, Spray TL. Use of aprotinin in pediatric lung transplantation. J Heart Lung Transplant.1995;14(2):302-7.